Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPironolactone Versus Amiloride for Treatment of REsistant Hypertension (SPARE Trial): A Comparison of Home Blood Pressure

NCT04331691 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT04331691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04331691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPironolactone Versus Amiloride for Treatment of REsistant Hypertension (SPARE Trial): A Comparison of Home Blood Pressure
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Completed
Start date
November 16, 2020
Completion date
May 23, 2024
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resistant hypertension